VKTX – viking therapeutics, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Days Volatility
Open
Prior Close

YTD

1 Day

VKTX

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

11/20

04:15 pm

vktx

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc. - VKTX

Medium Report

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc. - VKTX

Report

11/20

01:41 pm

vktx

Viking Therapeutics Garners Analyst Support For NASH And Metabolic Programs [Yahoo! Finance]

Low Report

Viking Therapeutics Garners Analyst Support For NASH And Metabolic Programs [Yahoo! Finance]

Report

11/20

11:36 am

vktx

Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "outperform" rating re-affirmed by analysts at William Blair.

Low Report

Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "outperform" rating re-affirmed by analysts at William Blair.

Report

11/20

07:30 am

vktx

VKTX ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Viking Therapeutics, Inc.

Low Report

VKTX ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Viking Therapeutics, Inc.

Report

11/19

04:11 pm

vktx

Viking Therapeutics Presents Results from Phase 2b VOYAGE Study of VK2809 in Biopsy-Confirmed NASH/MASH at the 75th Liver Meeting® 2024 [Yahoo! Finance]

Low Report

Viking Therapeutics Presents Results from Phase 2b VOYAGE Study of VK2809 in Biopsy-Confirmed NASH/MASH at the 75th Liver Meeting® 2024 [Yahoo! Finance]

Report

11/19

04:03 pm

vktx

Viking Therapeutics Presents Results from Phase 2b VOYAGE Study of VK2809 in Biopsy-Confirmed NASH/MASH at the 75th Liver Meeting® 2024

Low Report

Viking Therapeutics Presents Results from Phase 2b VOYAGE Study of VK2809 in Biopsy-Confirmed NASH/MASH at the 75th Liver Meeting® 2024

Report

11/18

10:15 pm

vktx

Did Viking Therapeutics, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - VKTX

Medium Report

Did Viking Therapeutics, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - VKTX

Report

11/18

09:52 pm

vktx

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc. - VKTX

Medium Report

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc. - VKTX

Report

Date

Time

Symbol

Company Name

Action

%Chg

10/23/2024

04:05 pm

vktx

viking therapeutics, inc.

BEAT Report

20.1%

viking therapeutics, inc.

Report

7/24/2024

04:05 pm

vktx

viking therapeutics, inc.

BEAT Report

29.1%

viking therapeutics, inc.

Report

4/24/2024

04:05 pm

vktx

viking therapeutics, inc.

BEAT Report

5.8%

viking therapeutics, inc.

Report

2/7/2024

04:05 pm

vktx

viking therapeutics, inc.

IN-LINE Report

18.4%

viking therapeutics, inc.

Report

Date

Time

Action

From

Firm

Impact

%Chg

11/20

11:36 am

Reiterates

Outperform

William Blair

Low

Report

-1.6%

Report

11/20

11:36 am

Reiterates

Outperform

William Blair

Low

Report

-1.6%

Report

10/24

08:08 am

Reiterates

Buy

HC Wainwright

High

Report

15.1%

Report

10/9

10:52 am

Reiterates

Buy

HC Wainwright

Low

Report

-2.4%

Report

9/25

02:04 pm

Reiterates

Outperform

Oppenheimer Holdings Inc.

Low

Report

-1.8%

Report

9/25

01:49 pm

Reiterates

Outperform

Oppenheimer

Low

Report

-1.4%

Report

9/25

01:49 pm

Reiterates

Outperform

Oppenheimer

Low

Report

-1.4%

Report

9/12

08:55 am

Reiterates

Overweight

Morgan Stanley

Low

Report

-0.1%

Report

Date

Time

Symbol

Headline

Impact

11/14

04:31 pm

vktx

Form SC 13G/A Viking Therapeutics, Filed by: VIKING GLOBAL INVESTORS LP

Medium Report

Form SC 13G/A Viking Therapeutics, Filed by: VIKING GLOBAL INVESTORS LP

Report

11/12

05:55 pm

vktx

Form SC 13G/A Viking Therapeutics, Filed by: VANGUARD GROUP INC

High Report

Form SC 13G/A Viking Therapeutics, Filed by: VANGUARD GROUP INC

Report

11/8

06:23 pm

vktx

Form 4 Viking Therapeutics, For: Nov 08 Filed by: MACARTNEY LAWSON

Medium Report

Form 4 Viking Therapeutics, For: Nov 08 Filed by: MACARTNEY LAWSON

Report

11/8

06:14 pm

vktx

Form 144 Viking Therapeutics, Filed by: MACARTNEY LAWSON

Medium Report

Form 144 Viking Therapeutics, Filed by: MACARTNEY LAWSON

Report

11/4

01:55 pm

vktx

Form SC 13G/A Viking Therapeutics, Filed by: VANGUARD GROUP INC

Medium Report

Form SC 13G/A Viking Therapeutics, Filed by: VANGUARD GROUP INC

Report

11/4

06:32 am

vktx

Form 8-K Viking Therapeutics, For: Nov 04

High Report

Form 8-K Viking Therapeutics, For: Nov 04

Report

10/28

09:48 pm

vktx

Form 4 Viking Therapeutics, For: Oct 28 Filed by: ZANTE GREG

Low Report

Form 4 Viking Therapeutics, For: Oct 28 Filed by: ZANTE GREG

Report

10/28

04:38 pm

vktx

Form 144 Viking Therapeutics, Filed by: ZANTE GREG

Low Report

Form 144 Viking Therapeutics, Filed by: ZANTE GREG

Report

Stock Stats

News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings

Order Stats
Sub-Penny

Odd lot

Avg. bid-ask spread

Avg. bid-ask size

Shares at ask/bid

Off exchange

Main News & Impact Reports

Don’t Miss Out On The Next BIG Stock Move

Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.